Aiphanol, a native compound, suppresses angiogenesis via dual-targeting VEGFR2 and COX2

  • Signal Transduct Target Ther. 2021 Dec 3;6(1):413. doi: 10.1038/s41392-021-00739-5.
Shanmei Chen  1 ,  Junnan Feng  1  2 ,  Chuanke Zhao  3 ,  Lixin Wang  1 ,  Lin Meng  1 ,  Caiyun Liu  1 ,  Shaoqing Cai  4 ,  Yanxing Jia  4 ,  Like Qu  5 ,  Chengchao Shou  6
Affiliations
  • 1. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Biochemistry and Molecular Biology, Peking University Cancer Hospital & Institute, Beijing, China.
  • 2. Key Laboratory of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
  • 3. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Biochemistry and Molecular Biology, Peking University Cancer Hospital & Institute, Beijing, China. [email protected].
  • 4. Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, China.
  • 5. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Biochemistry and Molecular Biology, Peking University Cancer Hospital & Institute, Beijing, China. [email protected].
  • 6. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Biochemistry and Molecular Biology, Peking University Cancer Hospital & Institute, Beijing, China. [email protected].
PMID: 34862391 DOI: 10.1038/s41392-021-00739-5
Products